Ovid Therapeutics, Inc. (OVID)

1.62 -0.03 (-1.82%) USD  |  NASDAQ  |  Feb 27, 11:33
More

Ovid Therapeutics Stock Based Compensation (Annual)

Stock Based Compensation (Annual) Chart

View Stock Based Compensation (Annual) for OVID.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Stock Based Compensation (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Stock Based Compensation (Annual) Range, Past 5 Years

View Stock Based Compensation (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Stock Based Compensation (Annual) Benchmarks

View Stock Based Compensation (Annual) Benchmarks
Start Trial
Cassava Sciences, Inc. Upgrade
PTC Therapeutics, Inc. Upgrade
ACADIA Pharmaceuticals, Inc. --
Alnylam Pharmaceuticals, Inc. Upgrade
Savara, Inc. Upgrade